• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-17

  The reference study shows that puerarin promotes osteogenic differentiation of rat dental follicle cells while increasing nitric oxide, cyclic GMP, and osteogenic markers. Pharmacological inhibition with L-NMMA reversed these effects, supporting a nitric oxide–soluble guanylate cyclase–PKG mechanism, although the findings remain limited to an in vitro rat-cell model.

• Tubastatin A: Mapping HDAC6-Linked Cell Death

  2026-08-17

  Tubastatin A is a selective HDAC6 inhibitor with utility beyond proliferation assays. This article explains how a porcine cardiac-arrest study connects HDAC6 signaling with pyroptosis, necroptosis, inflammation, and practical assay design.

• Pioglitazone: Mapping PPARγ in Inflammation

  2026-08-16

  Pioglitazone is a PPARγ agonist with value beyond metabolic studies. This evidence-focused guide shows how to use receptor activation, macrophage polarization, STAT signaling, and intestinal barrier readouts to build more interpretable inflammation assays.

• Talin1 and the Piezo1–YAP Axis in Atherosclerosis

  2026-08-15

  This study identifies Talin1 as a mechanistic link between Piezo1-dependent calcium entry, YAP activation, and inflammatory responses in endothelial cells exposed to atherosclerosis-relevant stimuli. Its combined mouse and endothelial-cell models suggest that Talin1 may be a more specific anti-inflammatory target than broad immunosuppression, while also defining important limits for translating the findings to other calcium-dependent systems.

• Vemurafenib: A State-Aware Melanoma Assay

  2026-08-14

  Vemurafenib and PLX4032 provide a precise way to interrogate mutant BRAF signaling, but assay interpretation depends on cellular state, timing, and resistance context. This guide translates multi-omics findings into practical workflows for melanoma cell proliferation inhibition, resistance analysis, and translational cancer biology.

• Arginine–Lipid Crosstalk in Cancer Research

  2026-08-14

  A translational framework for using nor-NOHA acetate to interrogate arginine metabolism, tumor biology, endothelial function, and emerging lipid-driven immune escape mechanisms.

• Cholecystokinin octapeptide ammonium: Assay Guide

  2026-08-13

  Cholecystokinin octapeptide ammonium provides a sulfated CCK-8 platform for dissecting receptor signaling, neuronal protection, immune modulation, and cardiac peptide secretion. This practical guide connects concentration selection and CNS dosing with formulation controls, assay design, and troubleshooting strategies.

• Rotavirus Infection Suppresses Nrf2 Redox Defense

  2026-08-13

  The reference study identifies a biphasic response in which rotavirus initially induces Nrf2 during an oxidative burst but later drives marked Nrf2 depletion, nuclear loss, and suppression of antioxidant transcription. Its perturbation-based design distinguishes early redox-sensitive activation from later proteasome-associated degradation, providing a mechanistic framework for oxidative stress research in viral infection models.

• MLN8237 (Alisertib) for Reliable Cell Assays

  2026-08-12

  This scenario-based guide explains how MLN8237 (Alisertib), SKU A4110, can support more interpretable viability, proliferation, and apoptosis experiments. It connects biochemical potency, formulation constraints, assay design, and orthogonal validation without treating a kinase IC50 as a universal cellular benchmark.

• Deracoxib Workflows for COX-2 and Canine Cancer

  2026-08-12

  Deracoxib connects selective COX-2 inhibition with practical workflows for canine pain, inflammation, and tumor-cell studies. Its value is greatest when concentration, exposure time, cell type, and apoptosis readouts are calibrated together rather than treated as interchangeable variables.

• Cefazedone (Refosporen) in Cell Assays

  2026-08-11

  A scenario-driven guide to using Cefazedone (Refosporen), SKU BA1102, in antibacterial controls that accompany cell viability, proliferation, and cytotoxicity workflows. It separates bacterial MIC evidence from mammalian assay interpretation while covering formulation, storage, controls, and vendor-selection criteria.

• Decitabine Workflow for Gastric Cancer Epigenetics

  2026-08-11

  Decitabine enables a practical test of whether DNA hypermethylation is driving tumor suppressor silencing rather than merely accompanying it. This workflow connects promoter methylation, HNF4A reactivation, epithelial polarity, EMT signaling, and immune-response assays in a controlled experimental sequence.

• AP-2α Suppresses MGMT in Recurrent GBM

  2026-08-10

  This study identifies AP-2α as a transcriptional suppressor of MGMT in temozolomide-resistant recurrent glioma and connects its loss to impaired DNA damage and treatment resistance. It further shows that retinoic acid can activate the RAR/RXR–AP-2α pathway, providing a mechanistic framework for restoring temozolomide sensitivity in cellular and intracranial models.

• Cholecystokinin octapeptide Ammonium: Cell Assays

  2026-08-09

  Cholecystokinin octapeptide ammonium enables receptor-aware workflows spanning LPS-activated B-cell assays, neuronal apoptosis studies, behavioral models, and ANP secretion research. This practical guide emphasizes sulfation-dependent activity, concentration scouting, fresh solution handling, and controls that distinguish CCK1R from CCK2R biology.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-08

  The reference study identifies nitric oxide signaling as a mechanistic contributor to puerarin-induced osteogenic differentiation in rat dental follicle cells. By combining osteogenic markers with pharmacological NOS inhibition, it links puerarin treatment to the NO–cGMP–SGC/PKG-1 axis and provides a useful framework for periodontal regeneration research.

16974 records 1/1132 page Next 12345 下5页 Last page